Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Other Non Operating Income (2016 - 2026)

Phibro Animal Health has reported Other Non Operating Income over the past 14 years, most recently at -$2.1 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 81.67% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$812000.0, up 96.28%, while the annual FY2025 figure was -$7.9 million, 67.02% up from the prior year.
  • Other Non Operating Income for Q4 2025 was -$2.1 million at Phibro Animal Health, up from -$2.9 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $10.6 million in Q1 2022 and troughed at -$11.7 million in Q4 2024.
  • A 5-year average of -$1.6 million and a median of -$1.7 million in 2021 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: surged 1712.01% in 2022 and later tumbled 5118.12% in 2023.
  • Year by year, Other Non Operating Income stood at $4.2 million in 2021, then plummeted by 96.44% to $149000.0 in 2022, then tumbled by 5118.12% to -$7.5 million in 2023, then tumbled by 56.47% to -$11.7 million in 2024, then skyrocketed by 81.67% to -$2.1 million in 2025.
  • Business Quant data shows Other Non Operating Income for PAHC at -$2.1 million in Q4 2025, -$2.9 million in Q3 2025, and -$1.3 million in Q2 2025.